News

  Kobe University has decided to establish an International Clinical Cancer Research Center on Port Island to facilitate cooperation with the Kobe Biomedical Innovation Cluster, which is mainly promoted by Kobe City, in order to expand and improve the functions of medical care, research and education. This center promotes advanced surgical treatment for cancer as well as research and development of next-generation medical care and new medical devices, and serves as an international center for medical research and education in cooperation with the Kobe University Graduate School of Medicine and the School of Medicine and Kobe University Hospital.

  Sysmex has a global network of businesses, mainly in the field of in vitro diagnostics, and has recently entered into the field of cancer diagnostics. Our technologies are combined with the technologies and knowledge of universities, research institutes, and companies to create new clinical value, such as liquid biopsy using blood and bodily fluids, instead of conventional cell tissue tests. Currently, we are promoting research and development to contribute to personalized medicine using our measurement technology platforms of genes, cells, and proteins.

  By making a donation to the International Clinical Cancer Research Center, Sysmex will contribute to Kobe City, promote clinical trials and studies on next-generation medical care such as personalized medicine, and will actively promote exchanges with foreign medical facilities and researchers.
  We will continue to promote industry-government-academia cooperation, and develop advanced high-value-added testing and diagnoses for the early detection and treatment of diseases such as cancer.